[go: up one dir, main page]

MX16829A - Procedimiento para la preparacion de una sal formada por ranitidina y un complejo de bismuto con un acido carboxilico. - Google Patents

Procedimiento para la preparacion de una sal formada por ranitidina y un complejo de bismuto con un acido carboxilico.

Info

Publication number
MX16829A
MX16829A MX1682989A MX1682989A MX16829A MX 16829 A MX16829 A MX 16829A MX 1682989 A MX1682989 A MX 1682989A MX 1682989 A MX1682989 A MX 1682989A MX 16829 A MX16829 A MX 16829A
Authority
MX
Mexico
Prior art keywords
bismute
ranitidine
complex
procedure
preparation
Prior art date
Application number
MX1682989A
Other languages
English (en)
Other versions
MX174145B (es
Inventor
John Watson Clitherow
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888817098A external-priority patent/GB8817098D0/en
Priority claimed from GB898904686A external-priority patent/GB8904686D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of MX16829A publication Critical patent/MX16829A/es
Publication of MX174145B publication Critical patent/MX174145B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MX1682989A 1988-07-18 1989-07-17 Procedimiento para la preparacion de una sal formada por ranitidina y un complejo de bismuto con un acido carboxilico MX174145B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888817098A GB8817098D0 (en) 1988-07-18 1988-07-18 Chemical compounds
GB898904686A GB8904686D0 (en) 1989-03-01 1989-03-01 Chemical compounds

Publications (2)

Publication Number Publication Date
MX16829A true MX16829A (es) 1993-10-01
MX174145B MX174145B (es) 1994-04-25

Family

ID=26294175

Family Applications (1)

Application Number Title Priority Date Filing Date
MX1682989A MX174145B (es) 1988-07-18 1989-07-17 Procedimiento para la preparacion de una sal formada por ranitidina y un complejo de bismuto con un acido carboxilico

Country Status (35)

Country Link
US (1) US5008256A (es)
JP (1) JP2523185B2 (es)
KR (1) KR0122598B1 (es)
CN (1) CN1022626C (es)
AT (1) AT398200B (es)
AU (1) AU632052B2 (es)
BE (1) BE1003254A5 (es)
CA (1) CA1332610C (es)
CH (1) CH679582A5 (es)
CY (1) CY1650A (es)
DE (1) DE3923638C2 (es)
DK (1) DK168381B1 (es)
EG (1) EG19368A (es)
ES (1) ES2014175A6 (es)
FI (1) FI90538C (es)
FR (1) FR2634122B1 (es)
GB (1) GB2220937B (es)
GR (1) GR1000431B (es)
HK (1) HK61392A (es)
HU (2) HU206104B (es)
IE (1) IE61076B1 (es)
IL (1) IL91005A (es)
IT (1) IT1231481B (es)
LU (2) LU88722I2 (es)
MX (1) MX174145B (es)
MY (1) MY104055A (es)
NL (2) NL192604C (es)
NO (2) NO176319C (es)
NZ (1) NZ229958A (es)
PL (1) PL162391B1 (es)
PT (1) PT91188B (es)
SE (1) SE468715B (es)
SG (1) SG51992G (es)
YU (1) YU47021B (es)
ZW (1) ZW8689A1 (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE81011T1 (de) * 1987-03-09 1992-10-15 Procter & Gamble Zusammensetzungen und ihre verwendung zur behandlung von magen-darmstoerungen.
IL85472A (en) * 1987-03-09 1991-06-30 Procter & Gamble Pharmaceutical compositions for treating gastrointestinal disorders
AU641903B2 (en) * 1988-10-26 1993-10-07 Glaxo Group Limited Carboxylic acid derivatives
GB9004328D0 (en) * 1990-02-27 1990-04-25 Glaxo Group Ltd Chemical compounds
GB9009240D0 (en) * 1990-04-25 1990-06-20 Glaxo Group Ltd Chemical compounds
GB9009437D0 (en) * 1990-04-26 1990-06-20 Glaxo Group Ltd Chemical compounds
KR100193933B1 (ko) * 1990-07-20 1999-06-15 에밀리오 캠포레시, 존 페르구손 비스무트와 폴리아크릴레이트와의 수용성 착체, 이의 제조 방법 및 상기 착체 또는 다른 비스무트염을 함유하는 궤양성 대장염 치료용 약제학적 조성물
GB9019875D0 (en) * 1990-09-11 1990-10-24 Glaxo Group Ltd Pharmaceutical compositions
US5128140A (en) * 1991-01-14 1992-07-07 The Procter & Gamble Company Swallowable pharmaceutical compositions
US5192752A (en) * 1991-01-14 1993-03-09 The Procter & Gamble Company Swallowable pharmaceutical compositions containing colloidal bismuth subcitrate
GB9120131D0 (en) * 1991-09-20 1991-11-06 Glaxo Group Ltd Medicaments
EP0550083B1 (en) * 1991-12-06 1999-03-24 Glaxo Group Limited Medicaments for treating inflammatory conditions or for analgesia containing a NSAID and ranitidine bismuth citrate
WO1996019232A1 (en) * 1994-12-19 1996-06-27 Lauteral Limited Combinations of ranitidine hydrochloride-form 1 and bismuth compounds
DE69620582T2 (de) * 1995-01-26 2002-11-07 Nycomed Imaging As, Oslo Verwendung von WISMUTVERBINDUNGEN zur Herstellung eines Arzneimittels zur Behandlung von Magenverstimmungen, die durch Helicobacter pylori verursacht werden
GB9501560D0 (en) 1995-01-26 1995-03-15 Nycomed Imaging As Contrast agents
EP1035192A1 (de) * 1999-01-26 2000-09-13 Stefan Graichen Additiv für einen Kühlschmierstoff
CN1102585C (zh) * 1999-04-28 2003-03-05 常州兰陵制药有限公司 雷尼替丁枸橼酸铋盐的制备方法
US20060100271A1 (en) * 2004-11-08 2006-05-11 Keith Whitehead Stabilized aqueous ranitidine compositions
CN100402514C (zh) * 2006-08-01 2008-07-16 丽珠医药集团股份有限公司 一种制备枸橼酸铋雷尼替丁的方法
AU2007216671B2 (en) * 2007-07-09 2009-07-16 Cypress Pharmaceutical, Inc. Pleasant-tasting ranitidine formulation
CN102408398B (zh) * 2011-09-20 2012-12-05 江苏汉斯通药业有限公司 枸橼酸铋雷尼替丁的制备方法
US9731999B2 (en) 2011-09-23 2017-08-15 Iqbal Gill Chemical admixtures for hydraulic cements
ES2426539B1 (es) * 2012-04-18 2014-09-09 Dr Healthcare España, S. L. Uso de la diaminooxidasa para el tratamiento o la prevención del trastorno por deficit de atencion con hiperactividad (adhd)
CN103896888B (zh) * 2014-03-28 2015-11-18 常州兰陵制药有限公司 枸橼酸铋雷尼替丁的制备方法
WO2015155297A1 (en) 2014-04-11 2015-10-15 Sanovel Ilac Sanayi Ve Ticaret A.S. Pharmaceutical combinations of dabigatran and h2-receptor antagonists
WO2015169957A1 (en) 2014-05-09 2015-11-12 Sanovel Ilac Sanayi Ve Ticaret A.S. Pharmaceutical combinations of rivaroxaban and h2-receptor antagonists
CN107382921A (zh) * 2017-07-28 2017-11-24 常州兰陵制药有限公司 制备枸橼酸铋雷尼替丁的方法
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
FR2531706A1 (fr) * 1982-08-13 1984-02-17 Sanofi Sa Benzamides, leurs sels, procede pour leur preparation et compositions pharmaceutiques les renfermant
BE905235A (fr) * 1986-08-05 1986-12-01 Hasunor Ag Ascorbates antagonistes des recepteurs h2 et leur procede de preparation.
IT1215325B (it) * 1987-01-07 1990-02-08 Barisintex Sa Composti antagonisti di recettori -h2 e procedimento per la loro preparazione.
ATE81011T1 (de) * 1987-03-09 1992-10-15 Procter & Gamble Zusammensetzungen und ihre verwendung zur behandlung von magen-darmstoerungen.
IL85472A (en) * 1987-03-09 1991-06-30 Procter & Gamble Pharmaceutical compositions for treating gastrointestinal disorders
DE3710462A1 (de) * 1987-03-30 1988-10-13 Heumann Pharma Gmbh & Co Pharmazeutische zubereitung zur behandlung von erkrankungen des magen-darm-traktes
GB9004328D0 (en) * 1990-02-27 1990-04-25 Glaxo Group Ltd Chemical compounds
GB9009437D0 (en) * 1990-04-26 1990-06-20 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
KR0122598B1 (ko) 1997-11-13
NL970046I1 (nl) 1998-03-02
FI893448A0 (fi) 1989-07-17
FR2634122B1 (fr) 1993-11-19
JPH02117684A (ja) 1990-05-02
AU632052B2 (en) 1992-12-17
GR890100454A (en) 1990-06-27
EG19368A (en) 1995-02-28
PT91188A (pt) 1990-02-08
AT398200B (de) 1994-10-25
CN1022626C (zh) 1993-11-03
SG51992G (en) 1992-07-24
ZW8689A1 (en) 1990-02-21
CA1332610C (en) 1994-10-18
MX174145B (es) 1994-04-25
CY1650A (en) 1992-12-11
DE3923638A1 (de) 1990-03-01
IE61076B1 (en) 1994-09-21
YU142789A (en) 1991-04-30
CH679582A5 (es) 1992-03-13
DK168381B1 (da) 1994-03-21
HUT52082A (en) 1990-06-28
FR2634122A1 (fr) 1990-01-19
HU211173A9 (en) 1995-11-28
YU47021B (sh) 1994-11-15
NL192604B (nl) 1997-07-01
JP2523185B2 (ja) 1996-08-07
GR1000431B (el) 1992-07-30
PL162391B1 (pl) 1993-10-30
NL970046I2 (nl) 1998-04-01
GB8916288D0 (en) 1989-08-31
LU87557A1 (fr) 1990-07-24
NZ229958A (en) 1991-09-25
FI893448A (fi) 1990-01-19
ES2014175A6 (es) 1990-06-16
DK351789D0 (da) 1989-07-17
NO892936D0 (no) 1989-07-17
DE3923638C2 (de) 1995-11-23
FI90538C (fi) 1994-02-25
GB2220937A (en) 1990-01-24
KR910002826A (ko) 1991-02-26
SE468715B (sv) 1993-03-08
LU88722I2 (fr) 1996-08-23
SE8902550D0 (sv) 1989-07-17
CN1039419A (zh) 1990-02-07
IL91005A0 (en) 1990-02-09
FI90538B (fi) 1993-11-15
HK61392A (en) 1992-08-21
PT91188B (pt) 1995-03-01
NO176319B (no) 1994-12-05
NO1998007I1 (no) 1998-02-05
AU3817889A (en) 1990-01-18
MY104055A (en) 1993-10-30
GB2220937B (en) 1991-11-27
HU206104B (en) 1992-08-28
ATA172889A (de) 1994-02-15
IL91005A (en) 1994-10-07
BE1003254A5 (fr) 1992-02-11
DK351789A (da) 1990-01-19
NL8901840A (nl) 1990-02-16
SE8902550L (sv) 1990-01-19
NL192604C (nl) 1997-11-04
IT1231481B (it) 1991-12-07
IE892309L (en) 1990-01-18
IT8948196A0 (it) 1989-07-17
US5008256A (en) 1991-04-16
NO176319C (no) 1995-03-15
NO892936L (no) 1990-01-19

Similar Documents

Publication Publication Date Title
MX16829A (es) Procedimiento para la preparacion de una sal formada por ranitidina y un complejo de bismuto con un acido carboxilico.
ES521728A0 (es) Un procedimiento para la preparacion de una sal de adicion de un acido bencenosulfonico de la sultamicilina.
NO861331L (no) Fremgangsmaate for fremstilling av et hyaluronsyresalt.
AR226062A1 (es) Un procedimiento para la preparacion de bis-esteres de metanodiol con penicilinas y 1,1-dioxido de acido penicilanico
ES509010A0 (es) Un procedimiento para la produccion de un dl- amino acido o una sal correspondiente.
DE69000881D1 (de) 2-propylvaleriansaeure enthaltende arzneizubereitung mit verzoegerter wirkstofffreigabe.
ES556467A0 (es) Un procedimiento para la preparacion de derivados de furanona.
ES531381A0 (es) Un procedimiento para la preparacion de sales metalicas de acidos fosforoditioicos y acidos carboxilicos.
ES529171A0 (es) Un procedimiento para la preparacion de una cefalosporina.
ES546840A0 (es) Un procedimiento para preparar una sal de acido n-acetil- neuraminico
ES534509A0 (es) Un procedimiento para la preparacion de acidos fenilquinolin-carboxilicos.
DE68913137D1 (de) Carbonsäure-Derivate.
DE3879450D1 (de) Ultraschallechograph mit modifizierter bildkadenz.
ES531814A0 (es) Procedimiento para la preparacion de nuevos derivados de acidos fenilalcanoicos.
ES508805A0 (es) Un procedimiento para la preparacion de derivados de acidos fenil-alcanoicos.
MX5721A (es) Sales de 5'-metiltio-5'-deoxiadenosina con acidos sulfonicos de cadena larga y procedimiento para su preparacion.
ES543491A0 (es) Un procedimiento para la preparacion de una sal metalica de un monoalquilfosfato.
ES530310A0 (es) Procedimiento para preparar derivados de acidos insaturados sustituidos con carboxialquiltio o carboxiamidoalquiltio.
ES518199A0 (es) Un procedimiento para producir una composicion inyectable acuosa de famotidina.
ES549853A0 (es) Un procedimiento para la preparacion de anilidas de acidos arilaceticos sustituidos.
AU615665B2 (en) Substituted phenylthioureseas, phenylisothioureas and phenylcabordiimides, their salts with organic and inorganic acids, processes and intermediates for their preparation, pesticidal compostions containing them, and their use in the control of pests.
ES529565A0 (es) Procedimiento de preparacion de eteres oximas basicos, y de sus sales de adicion acidas farmaceuticamente aceptables
DE3161125D1 (en) Process for the preparation of o,o-disubstituted benzoic acids and their salts
NO885446L (no) Fremgangsmaate for fremstilling av kinolincarboxylsyrer.
DE3852235D1 (de) Phenoxyalkancarboxylsäure-Derivate mit herbizider Wirkung.